Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study
Top Cited Papers
- 14 May 2020
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 43 (7), 1382-1391
- https://doi.org/10.2337/dc20-0598
Abstract
OBJECTIVE Diabetes is common in COVID-19 patients and associated with unfavorable outcomes. We aimed to describe the characteristics and outcomes and to analyze the risk factors for in-hospital mortality of COVID-19 patients with diabetes. RESEARCH DESIGN AND METHODS This two-center retrospective study was performed at two tertiary hospitals in Wuhan, China. Confirmed COVID-19 patients with diabetes (N = 153) who were discharged or died from 1 January 2020 to 8 March 2020 were identified. One sex- and age-matched COVID-19 patient without diabetes was randomly selected for each patient with diabetes. Demographic, clinical, and laboratory data were abstracted. Cox proportional hazards regression analyses were performed to identify the risk factors associated with the mortality in these patients. RESULTS Of 1,561 COVID-19 patients, 153 (9.8%) had diabetes, with a median age of 64.0 (interquartile range 56.0–72.0) years. A higher proportion of intensive care unit admission (17.6% vs. 7.8%, P = 0.01) and more fatal cases (20.3% vs. 10.5%, P = 0.017) were identified in COVID-19 patients with diabetes than in the matched patients. Multivariable Cox regression analyses of these 306 patients showed that hypertension (hazard ratio [HR] 2.50, 95% CI 1.30–4.78), cardiovascular disease (HR 2.24, 95% CI 1.19–4.23), and chronic pulmonary disease (HR 2.51, 95% CI 1.07–5.90) were independently associated with in-hospital death. Diabetes (HR 1.58, 95% CI 0.84–2.99) was not statistically significantly associated with in-hospital death after adjustment. Among patients with diabetes, nonsurvivors were older (76.0 vs. 63.0 years), most were male (71.0% vs. 29.0%), and they were more likely to have underlying hypertension (83.9% vs. 50.0%) and cardiovascular disease (45.2% vs. 14.8%) (all P values CONCLUSIONS COVID-19 patients with diabetes had worse outcomes compared with the sex- and age-matched patients without diabetes. Older age and comorbid hypertension independently contributed to in-hospital death of patients with diabetes.Funding Information
- National Natural Science Foundation of China (No. 81800574, No. 81870442)
This publication has 38 references indexed in Scilit:
- Cardiovascular Outcomes in Framingham Participants With DiabetesHypertension, 2011
- Diabetes and the Severity of Pandemic Influenza A (H1N1) InfectionDiabetes Care, 2010
- Type 2 Diabetes and Pneumonia OutcomesDiabetes Care, 2007
- Etiology and Outcome of Community-Acquired Pneumonia in Patients With Diabetes MellitusSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2005
- The Immunopathogenesis of Sepsis in Elderly PatientsClinical Infectious Diseases, 2005
- Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes MellitusClinical Infectious Diseases, 2005
- Multiple organ infection and the pathogenesis of SARSThe Journal of Experimental Medicine, 2005
- Diabetes and the Risk of Infection-Related Mortality in the U.S.Diabetes Care, 2001
- Infections in Patients with Diabetes MellitusThe New England Journal of Medicine, 1999
- Infections and Diabetes: Mechanisms and Prospects for PreventionDiabetic Medicine, 1994